Table of Contents
1 Table Of Contents
1.1 List of Tables
1.2 List of Figures
2 Clinical Trial Recruitment in Cardiovascular Diseases (CVD): Executive Summary
2.1 CVD is One of the Four Major Therapeutic Areas for Clinical Trials
2.2 Most CVD Patients Were Recruited For Venous Thromboembolism Clinical Trials, 2000-2009
2.3 Most Clinical Trials Were Conducted For Hypertension, 2000-2009
3 Clinical Trial Recruitment in CVD: Introduction
3.1 GBI Research Report Guidance
4 Clinical Trial Recruitment in CVD: Overview
4.1 Clinical Trials Share by Therapeutic Area, 2005-2010
4.2 Clinical Trials by Major Pharmaceutical Companies, 2005-2010
4.3 Clinical Trial and Patient Recruitment for Major Indications, 2000-2009
5 Clinical Trials and Patient Recruitment for Hypertension
5.1 Introduction
5.2 Number of Clinical Trials for Hypertension
5.2.1 Number of Clinical Trials by Phase
5.2.2 Number of Clinical Trials for Hypertension by Major Sponsors
5.2.3 Number of Clinical Trials for Hypertension by Geography
5.2.4 Number of Clinical Trials for Hypertension by Year
5.3 Prevalence Population for Hypertension (2010-2017)
5.3.1 Brazil
5.3.2 India
5.3.3 China
5.4 Patient Recruitment for Hypertension
5.4.1 Number of Patients Recruited by Phase of Clinical Trial
5.4.2 Number of Patients Recruited by Major Sponsors
5.4.3 Number of Patients Recruited by Geography
5.4.4 Number of Patients Recruited per Year
5.5 Average Number of Patients Recruited Per Trial
5.5.1 Average Number of Patients Recruited per Trial by Stage of Development
5.5.2 Average Number of Patients Recruited per Trial per Year
6 Clinical Trials and Patient Recruitment for Atherosclerosis
6.1 Introduction
6.2 Number of Clinical Trials for Atherosclerosis
6.2.1 Number of Clinical Trials by Phase
6.2.2 Number of Clinical Trials by Sponsor
6.2.3 Number of Clinical Trials by Geography
6.2.4 Number of Clinical Trials by Year
6.3 Prevalence Population for Atherosclerosis (2010-2017)
6.3.1 Brazil
6.3.2 India
6.3.3 China
6.4 Patient Recruitment for Atherosclerosis
6.4.1 Number of Patients Recruited By Phase of Clinical Trial
6.4.2 Number of Patients Recruited by Sponsor
6.4.3 Number of Patients Recruited by Geography
6.4.4 Number of Patients Recruited per Year
6.5 Average Number of Patients Recruited per Trial
6.5.1 Average Number of Patients Recruited per Trial by Stage of Development
6.5.2 Average Number of Patients Recruited per Trial per Year
7 Clinical Trials and Patient Recruitment for Dyslipidemia
7.1 Introduction
7.2 Number of Clinical Trials for Dyslipidemia
7.2.1 Number of Clinical Trials by Phase
7.2.2 Number of Clinical Trials by Major Sponsor
7.2.3 Number of Clinical Trials by Geography
7.2.4 Number of Clinical Trials by Year
7.3 Prevalence Population for Dyslipidemia (2010-2017)
7.3.1 Brazil
7.3.2 India
7.3.3 China
7.4 Patient Recruitment for Dyslipidemia
7.4.1 Number of Patients Recruited by Phase of Clinical Trial
7.4.2 Number of Patients Recruited by Major Sponsors
7.4.3 Number of Patients Recruited by Geography
7.4.4 Number of Patients Recruited per Year
7.5 Average Number of Patients Recruited per Trial
7.5.1 Average Number of Patients Recruited per Trial by Stage of Development
7.5.2 Average Number of Patients Recruited per Trial per Year
8 Clinical Trials and Patient Recruitment for Atrial Fibrillation
8.1 Introduction
8.2 Number of Clinical Trials for Atrial Fibrillation
8.2.1 Number of Clinical Trials by Phase
8.2.2 Number of Clinical Trials by Major Sponsors
8.2.3 Number of Clinical Trials by Geography
8.2.4 Number of Clinical Trials by Year
8.3 Prevalence Population for Atrial Fibrillation (2010-2017)
8.3.1 Brazil
8.3.2 India
8.3.3 China
8.4 Patient Recruitment for Atrial Fibrillation
8.4.1 Number of Patients Recruited by Phase of Clinical Trial
8.4.2 Number of Patients Recruited by Major Sponsors
8.4.3 Number of Patients Recruited by Geography
8.4.4 Number of Patients Recruited per Year
8.5 Average Number of Patients Recruited Per Trial
8.5.1 Average Number of Patients Recruited per Trial by Stage of Development
8.5.2 Average Number of Patients Recruited per Trial per Year
9 Clinical Trials and Patient Recruitment for Venous Thromboembolism
9.1 Introduction
9.2 Number of Clinical Trials for Venous Thromboembolism
9.2.1 Number of Clinical Trials by Phase
9.2.2 Number of Clinical Trials by Sponsor
9.2.3 Number of Clinical Trials by Geography
9.2.4 Number of Clinical Trials by Year
9.3 Prevalence Population for Venous Thromboembolism (2010-2017)
9.3.1 Brazil
9.3.2 India
9.3.3 China
9.4 Patient Recruitment for Venous Thromboembolism
9.4.1 Number of Patients Recruited By Phase of Clinical Trial
9.4.2 Number of Patients Recruited by Major Sponsors
9.4.3 Number of Patients Recruited By Geography
9.4.4 Number of Patients Recruited Per Year
9.5 Average Number of Patients Recruited per Trial
9.5.1 Average Number of Patients Recruited per Trial by Stage of Development
9.5.2 Average Number of Patients Recruited per Trial per Year
10 Appendix
10.1 Market Definitions
10.2 Abbreviations
10.3 Research Methodology
10.3.1 Clinical Trials Overview
10.3.2 Number of Clinical Trials
10.3.3 Patient Recruitment Status
10.3.4 Prevalence of Disease in India, China and Brazil (2010-2017)
10.4 Coverage
10.5 Secondary Research
10.6 Primary Research
10.7 Expert Panel Validation
10.8 Contact Us
10.9 Disclaimer
10.10 Sources